Best out of 4,000 strains to support cardiometabolic health
LPLDL®
was selected in pre-clinical studies, from a collection of over 4,000 microbial candidates, using ProBiotix’s ProScreen technology platform, for its superior:
- Bile salt hydrolase activity
- Rate of bile salt hydrolysis
- Cholesterol reduction activity
- Survival and metabolic activity in high concentrations of bile salts
- Manufacturing suitability.